1)Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive registry of esophageal cancer in Japan, 2012. Esophagus 16:221-245, 2019
2)Katada C, Muto M, Tanabe S, et al. Surveillance after endoscopic mucosal resection or endoscopic submucosal dissection for esophageal squamous cell carcinoma. Dig Endosc 25:39-43, 2013
3)Uno K, Koike T, Kusaka G, et al. Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma. Dis Esophagus 30:1-8, 2017
4)Katada C, Yokoyama T, Yano T, et al. Alcohol consumption and multiple dysplastic lesions increase risk of squamous cell carcinoma in the esophagus, head, and neck. Gastroenterology 151:860-869, 2016
5)Nonaka K, Miyazawa M, Ban S, et al. Different healing process of esophageal large mucosal defects by endoscopic mucosal dissection between with and without steroid injection in an animal model. BMC Gastroenterol 13:72, 2013
6)日本食道学会(編).臨床・病理食道癌取扱い規約,第12版.金原出版,2022
7)河内洋,中野薫.扁平上皮内腫瘍.腫瘍病理鑑別診断アトラス刊行委員(監),大橋健一,河内洋(編).腫瘍病理鑑別診断アトラス 食道癌,第2版.文光堂,pp 38-45, 2021
8)根本哲生.hyperkeratosis,hyperparakeratosis.胃と腸 52:704, 2017
9)桜井孝規.角化細胞性腫瘍 総論.腫瘍病理鑑別診断アトラス刊行委員(監),真鍋俊明,清水道生(編).腫瘍病理鑑別診断アトラス 皮膚腫瘍I—角化細胞性腫瘍,付属器系腫瘍と皮膚特有の間葉系腫瘍.文光堂,pp 16-18, 2010
10)Takubo K, Fujii S. Oesophageal squamous dysplasia. WHO Classification of Tumours Editorial Board(eds). WHO Classification of Tumours, Digestive System Tumours, 5th ed, IARC press, Lyon, pp 36-37, 2019
11)Kobayashi M, Kawachi H, Takizawa T, et al. p53 Mutation analysis of low-grade dysplasia and high-grade dysplasia/carcinoma in situ of the esophagus using laser capture microdissection. Oncology 71:237-245, 2006
12)真能正幸,石黒信吾,春日井務,他.食道癌の発育進展—脈管侵襲,リンパ節転移,食道導管内進展を中心に.胃と腸 35:503-510, 2000